Handbook of Analysis of Oligonucleotides and Related Products
Crc Press Inc (Verlag)
978-1-4398-1993-7 (ISBN)
Topics discussed include:
Strategies for enzymatic or chemical degradation of chemically modified oligonucleotides toward mass spectrometric sequencing
Purity analysis by chromatographic or electrophoretic methods, including RP-HPLC, AX-HPLC, HILIC, SEC, and CGE
Characterization of sequence-related impurities in oligonucleotides by mass spectrometry and chromatography
Structure elucidation by spectroscopic methods (IR, NMR, MS) as well as base composition and thermal melt analysis (Tm)
Approaches for the accurate determination of molar extinction coefficient of oligonucleotides
Accurate determination of assay values
Assessment of the overall quality of oligonucleotides, including microbial analysis and determination of residual solvents and heavy metals
Strategies for determining the chemical stability of oligonucleotides
The use of hybridization techniques for supporting pharmacokinetics and drug metabolism studies in preclinical and clinical development
Guidance for the presentation of relevant analytical information towards meeting current regulatory expectations for oligonucleotide therapeutics
This resource provides a practical guide for applying state-of-the-art analytical techniques in research, development, and manufacturing settings.
Dr. Jose V. Bonilla’s career has been dedicated to the introduction and implementation of cutting-edge analytical technologies such as LC-MS, high-speed gas chromatography, high-speed GPC, online GC, online HPLC, and online near-IR. He has extensive experience in the management of industrial and pharmaceutical analytical laboratories in compliance with regulatory requirements and is the author and coauthor of several peer-reviewed publications. Dr. G. Susan Srivatsa has more than 20 years of experience in the development of small molecules, proteins, peptides, and oligonucleotides as therapeutics. She has contributed to the successful development of more than 35 DNA and RNA oligonucleotide drug candidates through various stages of clinical development and has published widely in the area of oligonucleotide analysis in peer-reviewed journals.
Purity Analysis and Impurities Determination by Reversed-Phase High- Performance Liquid Chromatography. Purity Analysis and Impurities Determination by AEX-HPLC. Purity Analysis and Molecular Weight Determination by Size Exclusion HPLC Analysis. Analysis of Oligonucleotides by Liquid Chromatography—Mass Spectrometry. Sequence Determination and Confirmation by MS/M S and MALDI-TOF. Tm Analysis of Oligonucleotides. Purity and Content Analysis of Oligonucleotides by Capillary Gel Electrophoresis. Bioanalysis of Therapeutic Oligonucleotides Using Hybridization-Based Immunoassay Techniques. Oligonucleotide Assay and Potency. Microbial Analysis: Endotoxin Testing. Analysis of Residual Solvents by Head Space Gas Chromatography. Determination of Extinction Coefficient. Structural Determination by NMR. Infrared Analysis of Oligonucleotides. Stability Indicating Methods for Oligonucleotide Products. Analysis by Hydrophilic Interaction Chromatography. Determination of Base Composition. Analysis of Metals in Oligonucleotides. Regulatory Considerations for the Development of Oligonucleotide Therapeutics.
Erscheint lt. Verlag | 2.3.2011 |
---|---|
Zusatzinfo | 76 Tables, black and white; 266 Illustrations, black and white |
Verlagsort | Bosa Roca |
Sprache | englisch |
Maße | 178 x 254 mm |
Gewicht | 1400 g |
Themenwelt | Informatik ► Weitere Themen ► Bioinformatik |
Medizin / Pharmazie ► Pflege | |
Naturwissenschaften ► Biologie ► Genetik / Molekularbiologie | |
Naturwissenschaften ► Chemie ► Analytische Chemie | |
Technik ► Medizintechnik | |
Technik ► Umwelttechnik / Biotechnologie | |
ISBN-10 | 1-4398-1993-9 / 1439819939 |
ISBN-13 | 978-1-4398-1993-7 / 9781439819937 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich